Ciro Pharma Profile
Key Indicators
- Authorised Capital ₹ 95.00 Cr
- Paid Up Capital ₹ 95.00 Cr
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 140.00 Cr
About Ciro Pharma
Ciro Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2021 (Three years and seven months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 95.00 Cr and a paid-up capital of Rs 95.00 Cr.
The company currently has active open charges totaling ₹140.00 Cr.
The Key Managerial Personnel (KMP) at Ciro Pharma Private Limited India is Harpreet Kaur as COMPANY SECRETARY. Yadamakanti Reddy, Govindareddy Katireddy, Someshwar Komuravelli, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24304TG2021PTC152989
-
Company No.
152989
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jul 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ciro Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindareddy Katireddy
|
Managing Director | 09-Jul-2021 | Current |
|
Harpreet Kaur
|
Company Secretary | 01-Mar-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Yadamakanti Reddy
|
Director | 09-Jul-2021 | Current |
|
Someshwar Komuravelli
|
Director | 08-Feb-2022 | Current |
|
Harshitha Katireddy
|
Director | 09-Jul-2021 | Current |
Financial Performance of Ciro Pharma.
Ciro Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ciro Pharma?
In 2023, Ciro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tif Integrated Industrial Parks Private LimitedGovindareddy Katireddy is a mutual person
-
G-Roc Mining And Construction Private LimitedGovindareddy Katireddy is a mutual person
-
Cns Labs Private LimitedYadamakanti Reddy is a mutual person
-
Cygnus Micro Systems Pvt LtdGovindareddy Katireddy is a mutual person
-
Bell Pharmaceuticals And Cosmetics Private LimitedYadamakanti Reddy and Someshwar Komuravelli are mutual person
-
Ciro Labs Private Limited
Yadamakanti Reddy, Govindareddy Katireddy and 1 more are mutual person
Charges (Loans)
₹140.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 140.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 2023 | Others | ₹120.00 Cr | Open |
| 05 Jan 2023 | Others | ₹20.00 Cr | Open |
How Many Employees Work at Ciro Pharma?
Unlock and access historical data on people associated with Ciro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ciro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
